Shares of Aspen Pharmacare (OTCMKTS:APNHY – Get Free Report) saw unusually-strong trading volume on Monday. Approximately 50,000 shares traded hands during trading, an increase of 4,174% from the average daily volume of 1,170 shares. The stock last traded at $10.00 and had previously closed at $10.04.
Aspen Pharmacare Stock Down 0.4%
The company has a debt-to-equity ratio of 0.12, a current ratio of 2.54 and a quick ratio of 1.68. The firm has a 50-day moving average price of $9.61 and a 200 day moving average price of $8.69.
Aspen Pharmacare Company Profile
Aspen Pharmacare is a South African pharmaceutical company headquartered in Durban. Founded in 1997, it develops, manufactures and markets branded and generic medicines for patients and healthcare providers.
The company’s product portfolio includes prescription and over-the-counter medicines across a range of therapeutic areas, as well as specialized products such as injectable medicines, anesthetics and treatments for thrombosis. Aspen also operates pharmaceutical manufacturing facilities and supplies medicines to other companies and healthcare markets.
Aspen serves markets in South Africa and other parts of Africa, as well as Europe, Asia-Pacific and Latin America.
Featured Articles
- Five stocks we like better than Aspen Pharmacare
- America’s Rare Earth Clock Is Running Out, But the Bottleneck Isn’t Where You Think
- Atlassian Tanks After Huge Run as Guidance Disappoints, But Strength Remains
- Lemonade’s Revenue Soars 73%—So Why Did Its Stock Turn Sour After Earnings?
- Anthropic’s S-1 Strengthens the Case for Broadcom’s AI Growth
Receive News & Ratings for Aspen Pharmacare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Pharmacare and related companies with MarketBeat.com's FREE daily email newsletter.
